These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 8630967
21. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver. Luedde T, Rodriguez ME, Tacke F, Xiong Y, Brenner DA, Trautwein C. Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976 [Abstract] [Full Text] [Related]
22. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors. Zariwala M, Xiong Y. Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552 [Abstract] [Full Text] [Related]
23. The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma. Miller CW, Yeon C, Aslo A, Mendoza S, Aytac U, Koeffler HP. Oncogene; 1997 Jul 10; 15(2):231-5. PubMed ID: 9244358 [Abstract] [Full Text] [Related]
24. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors. Zariwala M, Liu E, Xiong Y. Oncogene; 1996 Jan 18; 12(2):451-5. PubMed ID: 8570224 [Abstract] [Full Text] [Related]
25. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O. IUBMB Life; 2004 Sep 18; 56(9):557-64. PubMed ID: 15590562 [Abstract] [Full Text] [Related]
26. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Dahia PL, Aguiar RC, Honegger J, Fahlbush R, Jordan S, Lowe DG, Lu X, Clayton RN, Besser GM, Grossman AB. Oncogene; 1998 Jan 08; 16(1):69-76. PubMed ID: 9467944 [Abstract] [Full Text] [Related]
27. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. Tahara H, Smith AP, Gaz RD, Zariwala M, Xiong Y, Arnold A. J Bone Miner Res; 1997 Sep 08; 12(9):1330-4. PubMed ID: 9286748 [Abstract] [Full Text] [Related]
28. Absence of p18 mutations or deletions in lymphoid malignancies. Otsuki T, Jaffe ES, Wellmann A, Kumar S, Condron KS, Raffeld M. Leukemia; 1996 Feb 08; 10(2):356-60. PubMed ID: 8637248 [Abstract] [Full Text] [Related]
29. Alterations of the p15, p16,and p18 genes in osteosarcoma. Miller CW, Aslo A, Campbell MJ, Kawamata N, Lampkin BC, Koeffler HP. Cancer Genet Cytogenet; 1996 Feb 08; 86(2):136-42. PubMed ID: 8603340 [Abstract] [Full Text] [Related]
30. Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis. Kulkarni MS, Daggett JL, Bender TP, Kuehl WM, Bergsagel PL, Williams ME. Leukemia; 2002 Jan 08; 16(1):127-34. PubMed ID: 11840272 [Abstract] [Full Text] [Related]
31. Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia. Williams ME, Whitefield M, Swerdlow SH. Ann Oncol; 1997 Jan 08; 8 Suppl 2():71-3. PubMed ID: 9209645 [Abstract] [Full Text] [Related]
32. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B. Am J Pathol; 1995 Mar 08; 146(3):613-9. PubMed ID: 7887443 [Abstract] [Full Text] [Related]
33. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells. Komata T, Kanzawa T, Takeuchi H, Germano IM, Schreiber M, Kondo Y, Kondo S. Br J Cancer; 2003 Apr 22; 88(8):1277-80. PubMed ID: 12698196 [Abstract] [Full Text] [Related]
34. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N. Br J Haematol; 1995 Sep 22; 91(1):139-49. PubMed ID: 7577621 [Abstract] [Full Text] [Related]
35. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer. Shin JY, Kim HS, Lee KS, Kim J, Park JB, Won MH, Chae SW, Choi YH, Choi KC, Park YE, Lee JY. Exp Mol Med; 2000 Jun 30; 32(2):79-83. PubMed ID: 10926119 [Abstract] [Full Text] [Related]
36. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Rusin MR, Okamoto A, Chorazy M, Czyzewski K, Harasim J, Spillare EA, Hagiwara K, Hussain SP, Xiong Y, Demetrick DJ, Harris CC. Int J Cancer; 1996 Mar 15; 65(6):734-9. PubMed ID: 8631583 [Abstract] [Full Text] [Related]
37. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Blood; 1995 May 15; 85(10):2699-704. PubMed ID: 7742529 [Abstract] [Full Text] [Related]
38. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma. Tasaka T, Berenson J, Vescio R, Hirama T, Miller CW, Nagai M, Takahara J, Koeffler HP. Br J Haematol; 1997 Jan 15; 96(1):98-102. PubMed ID: 9012694 [Abstract] [Full Text] [Related]
39. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines. Gemma A, Takenoshita S, Hagiwara K, Okamoto A, Spillare EA, McMemamin MG, Hussain SP, Forrester K, Zariwala M, Xiong Y, Harris CC. Int J Cancer; 1996 Nov 27; 68(5):605-11. PubMed ID: 8938142 [Abstract] [Full Text] [Related]
40. Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes. Nakamaki T, Bartram C, Seriu T, Kahan J, Fukuchi K, Tsuruoka N, Janssen JW, Miller CW, Koeffler HP. Leuk Res; 1997 Mar 27; 21(3):235-40. PubMed ID: 9111168 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]